Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bisoprolol vs Bisoprolol and Hydrocortisone for AF Prophylaxis After CABG
NCT03800264Phase 4Completed
- Sponsor
- Ain Shams University
- Start
- May 2018
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of hydrocortisone in Atrial fibrillation (AFib), sponsored by Ain Shams University. Primary endpoint: Heart Rate at 2 days. Started May 2018; status: completed.
02
Drugs
hydrocortisone
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT03800264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03800264.